FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Patel Kinnary
   2. Issuer Name and Ticker or Trading Symbol
Greenwich LifeSciences, Inc. [GLSI] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O GREENWICH LIFESCIENCES, INC., 3992 BLUEBONNET DR., BUILDING 14		 3. Date of Earliest Transaction (Month/Day/Year)
09/29/2020
(Street)

STAFFORD, TX 77477		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/29/2020   M   76,780 A (5) 76,780 I see footnote (1)
Common Stock 09/29/2020   M   52,620 A (6) 129,400 I see footnote (1)
Common Stock               2,405,670 I see footnote (2)
Common Stock               1,320,226 I see footnote (3)
Common Stock               1,329,590 I see footnote (4)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series B Preferred Stock (5) 09/29/2020   M     76,780   (5)   (5) Common Stock 76,780 $ 0 0 I see footnote (1)
Series D Preferred Stock (6) 09/29/2020   M     45,328   (6)   (6) Common Stock 45,328 $ 0 0 I see footnote (1)
Series D Preferred Stock (7) 09/29/2020   J(8)   7,292     (7)   (7) Common Stock 7,292 $ 0 7,292 I see footnote (1)
Series D Preferred Stock (6) 09/29/2020   M     7,292   (6)   (6) Common Stock 7,292 $ 0 0 I see footnote (1)

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Patel Kinnary
C/O GREENWICH LIFESCIENCES, INC.
3992 BLUEBONNET DR., BUILDING 14
STAFFORD, TX 77477		     X    

Signatures

 /s/ Kinnary Patel   10/09/2020
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Kinnary Patel is the Trustee of the Kinnary Patel IRA and in such capacity has the right to vote and dispose of the securities held by such IRA.
(2) The securities are owned by Patel Family Trust 1. Kinnary Patel, as co-Trustee of Patel Family Trust 1, shares voting and dispositive power over the securities held by such trust with her spouse.
(3) The securities are owned by Patel Family Trust 2. Kinnary Patel, as co-Trustee of Patel Family Trust 2, shares voting and dispositive power over the securities held by such trust with her spouse.
(4) The securities are owned by Patel Family Trust 3. Kinnary Patel, as co-Trustee of Patel Family Trust 3, shares voting and dispositive power over the securities held by such trust with her spouse.
(5) The Series B Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
(6) The Series D Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
(7) The Series D Preferred Stock have no expiration date and are convertible, at the option of the holder, into shares of common stock of the Issuer at the then-effective conversion rate for no additional consideration (subject to the payment of cash, if applicable, in lieu of any fractional shares in accordance with the Issuer's Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation").
(8) The Reporting Person was issued additional shares of Series D Preferred Stock in connection with the Issuer's initial public offering as a result of the anti-dilution protection provisions set forth in the Issuer's Certificate of Incorporation.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.